Clover Health Investments (CLOV) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Clover Health Investments in October 2026.
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
Clover Health Investments (CLOV) Stock Forecast
Analyst price target, next 12 months
$3.04
-36.6% vs today's $4.79
Price range over the last 12 months
Close to its 12-month high
Analysts covering Clover Health Investments have a consensus 12-month target of $3.04, below the current price of $4.79.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 11 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Clover Health stock, with a target price of $3.04 indicating potential growth.
Financial Health
Clover Health is generating decent revenue and cash flow, but its book value per share is low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CLOV
Medicare Advantage Rate Hike Opportunities in 2026
The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.
Published: 10 April 2026
Explore BasketWhy invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
